Sinopia Biosciences (CHOmics Inc.), a small biotechnology company in San Diego, received a Phase I Small Business Innovation Research (SBIR) Grant from the National Heart, Lung, and Blood Institute (NHLBI) branch of the National Institutes of Health (NIH). The award for approximately $150,000 will support the development of bioinformatic methods and systems biology models of human erythrocytes to study the metabolic consequences of the red blood cell (RBC) storage lesion accumulated during RBC storage.